Disruption of the cutaneous barrier by surgery or physical trauma exposes underlying tissue to the environment and can lead to infection. A robust inflammatory response serves to combat exogenous pathogens in injured tissue and is tightly coupled to the process of repair. Prolonged or excessive inflammation can impede tissue repair, suggesting that prompt resolution of inflammation governs this transition. The relationship between resolution of inflammation and tissue repair is incompletely understood. Resolvins are a family of lipid mediators generated by immune cells that promote resolution of inflammation and also enhance host defense. Our recent evidence indicates that resolvins and related pro-resolving mediators also play an important role in tissue repair. Project 3 of this Program Project will test the hypothesis that D-series resolvins and their newly- identified sulfido-conjugates (SC) promote cutaneous tissue repair and combat infection following surgical excisional injury. To test this hypothesis, the following specific aims will be carried out: 1) Assess the role of resolvins in cutaneous re-epithelialization. We will determine whether resolvins promote re-epithelialization and determine its relationship to the resolution of inflammation with Projects 1 & 2; 2) Elucidate the temporal biosynthetic relationships and endogenous roles of D-series resolvins during the inflammatory, proliferative and remodeling phases of the injury-repair response. Through interactions with Cores B & C and Projects 1 & 2, we will determine how biosynthesis of D-series resolvins and their SC are regulated during resolution and tissue repair. We will determine how pro-resolving receptors for RvD1 and RvD2 impact re-epithelialization in cutaneous surgical injury; 3) Establish the mechanisms whereby resolvins promote re-epithelialization. Using primary keratinocytes cultured in 2D and 3D, we will determine how resolvins regulate differentiation, migration and proliferation in a receptor-dependent manner; and 4) Determine whether resolvins restore defective re- epithelialization by combating bacterial infection. Here, we will examine how infection with skin pathogen, Staphylococcus aureus, impacts local resolvin biosynthesis and whether resolvins promote bacterial containment and re-establish epidermal barrier function. Collectively, Project 3 will provide fundamental new knowledge about the roles of resolvins in tissue repair, which can lead to the development of new therapeutic approaches for enhancing tissue repair and host defense.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
2P01GM095467-06
Application #
9068637
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
6
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
Chiang, Nan; Riley, Ian R; Dalli, Jesmond et al. (2018) New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses. FASEB J 32:4043-4052
Krishnamoorthy, Nandini; Abdulnour, Raja-Elie E; Walker, Katherine H et al. (2018) Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 98:1335-1370
Chen, Gang; Zhang, Yu-Qiu; Qadri, Yawar J et al. (2018) Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 100:1292-1311
Tungen, J E; Aursnes, M; Ramon, S et al. (2018) Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents. Org Biomol Chem 16:6818-6823
Sulciner, Megan L; Serhan, Charles N; Gilligan, Molly M et al. (2018) Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med 215:115-140
Loynes, Catherine A; Lee, Jou A; Robertson, Anne L et al. (2018) PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo. Sci Adv 4:eaar8320
Zhang, Linlin; Terrando, Niccolò; Xu, Zhen-Zhong et al. (2018) Distinct Analgesic Actions of DHA and DHA-Derived Specialized Pro-Resolving Mediators on Post-operative Pain After Bone Fracture in Mice. Front Pharmacol 9:412
Dalli, Jesmond; Serhan, Charles N (2018) Immunoresolvents signaling molecules at intersection between the brain and immune system. Curr Opin Immunol 50:48-54
Norris, Paul C; Serhan, Charles N (2018) Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues. Biochem Biophys Res Commun 504:553-561
Werz, Oliver; Gerstmeier, Jana; Libreros, Stephania et al. (2018) Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun 9:59

Showing the most recent 10 out of 165 publications